Human brain derived cell culture models of HIV-1 infection

[1]  N. Sacktor,et al.  Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.

[2]  Kevin K W Wang,et al.  Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture , 2001, Journal of NeuroVirology.

[3]  J. Berman,et al.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat , 2011, Journal of NeuroVirology.

[4]  P. Fisher,et al.  Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: Potential role in neuropathogenesis , 2011, Journal of NeuroVirology.

[5]  K. Conant,et al.  Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases , 2011, Journal of NeuroVirology.

[6]  Yaakov Stern,et al.  HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.

[7]  尾上 富太郎.  Stromal cell-derived factor-1/CXCR4システムによる口腔癌のリンパ節転移・遠隔転移機構の解析 , 2007 .

[8]  J. Berman,et al.  HIV‐1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP‐1)‐dependent mechanism: Possible role in NeuroAIDS , 2005, Glia.

[9]  Sieghart Sopper,et al.  HIV-infection of the central nervous system: the tightrope walk of innate immunity. , 2005, Molecular immunology.

[10]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[11]  M. Churchill,et al.  Astrocyte specific viral strains in HIV dementia , 2004, Annals of neurology.

[12]  J. McArthur.  HIV dementia: an evolving disease , 2004, Journal of Neuroimmunology.

[13]  J. Bell,et al.  An update on the neuropathology of HIV in the HAART era , 2004, Histopathology.

[14]  R. Siliciano,et al.  The multifactorial nature of HIV-1 latency. , 2004, Trends in molecular medicine.

[15]  M. Cheeran,et al.  High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. , 2004, Brain research. Developmental brain research.

[16]  M. Krathwohl,et al.  HIV-1 promotes quiescence in human neural progenitor cells. , 2004, The Journal of infectious diseases.

[17]  D. Maric,et al.  Human Immunodeficiency Virus Type 1 Infection of Human Brain-Derived Progenitor Cells , 2004, Journal of Virology.

[18]  A. Nath,et al.  CD4-Independent Infection of Astrocytes by Human Immunodeficiency Virus Type 1: Requirement for the Human Mannose Receptor , 2004, Journal of Virology.

[19]  Jialin C. Zheng,et al.  Stromal cell‐derived factor 1‐mediated CXCR4 signaling in rat and human cortical neural progenitor cells , 2004, Journal of neuroscience research.

[20]  M. Krathwohl,et al.  Chemokines Promote Quiescence and Survival of Human Neural Progenitor Cells , 2004, Stem cells.

[21]  Bernhard Hennig,et al.  HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells , 2003, Journal of neuroscience research.

[22]  U. de Girolami,et al.  Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual , 2003, Neurology.

[23]  E. Major,et al.  Brain-Derived Neurotrophic Factor Inhibits Human Immunodeficiency Virus-1/gp120-Mediated Cerebellar Granule Cell Death by Preventing gp120 Internalization , 2003, The Journal of Neuroscience.

[24]  E. Major,et al.  Lineage pathway of human brain progenitor cells identified by JC virus susceptability , 2003, Annals of neurology.

[25]  E. Masliah,et al.  Changing Patterns in the Neuropathogenesis of HIV During the HAART Era , 2003, Brain pathology.

[26]  T. Menza,et al.  Detection of HIV‐1 DNA in Microglia/ Macrophages, Astrocytes and Neurons Isolated from Brain Tissue with HIV‐1 Encephalitis by Laser Capture Microdissection , 2003, Brain pathology.

[27]  N. Sacktor.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[28]  Markus Bickel,et al.  HIV‐Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[29]  D. Kolson.  Neuropathogenesis of central nervous system HIV-1 infection. , 2002, Clinics in laboratory medicine.

[30]  Sunhee C. Lee,et al.  GM‐CSF and M‐CSF modulate β‐chemokine and HIV‐1 expression in microglia , 2002 .

[31]  V. D’Agati,et al.  Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy , 2002, Nature Medicine.

[32]  Sunhee C. Lee,et al.  GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. , 2002, Glia.

[33]  C. Petito,et al.  Detection of HIV‐1 Gene Sequences in Hippocampal Neurons Isolated from Postmortem AIDS Brains by Laser Capture Microdissection , 2001, Journal of neuropathology and experimental neurology.

[34]  C. Chan,et al.  Molecular analysis of primary central nervous system and primary intraocular lymphomas. , 2001, Current molecular medicine.

[35]  R. Pomerantz,et al.  Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. , 2000, Journal of human virology.

[36]  O. Kutsch,et al.  Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes , 2000, Journal of Virology.

[37]  Andreas Hufnagel,et al.  Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[38]  J. Weiss,et al.  Mechanisms of leukocyte trafficking into the CNS. , 2000, Journal of neurovirology.

[39]  E. Major,et al.  Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. , 2000, Journal of neurovirology.

[40]  W. Powderly.  Current approaches to treatment for HIV-1 infection. , 2000, Journal of neurovirology.

[41]  M. Barcová,et al.  HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones , 2000, AIDS.

[42]  E. Masliah,et al.  Changes in pathological findings at autopsy in AIDS cases for the last 15 years , 2000, AIDS.

[43]  L. Brown,et al.  Children and adolescents living with HIV and AIDS: a review. , 2000, Journal of child psychology and psychiatry, and allied disciplines.

[44]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[45]  E. Major,et al.  Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. , 1999, Virology.

[46]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[47]  L. Sundstrom,et al.  A soluble factor produced by macrophages mediates the neurotoxic effects of HIV-1 Tat in vitro. , 1999, AIDS.

[48]  D. Vlahov,et al.  The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[49]  J. Kaldor,et al.  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. , 1999, AIDS.

[50]  R. Brack-Werner.  Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. , 1999, AIDS.

[51]  Clive N Svendsen,et al.  A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.

[52]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[53]  R. Miller,et al.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Michael Greenberg,et al.  Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4 , 1998, Current Biology.

[55]  E. Major,et al.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  U. de Girolami,et al.  Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. , 1998, The American journal of pathology.

[57]  J. Howard,et al.  Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication. , 1998, Journal of neurovirology.

[58]  D. Kolson,et al.  Chemokine receptors in the human brain and their relationship to HIV infection. , 1998, Journal of neurovirology.

[59]  J. Vincent,et al.  Human immunodeficiency virus type 1 and its coat protein gp 120 induce apoptosis and activate JNK and ERK mitogen‐activated protein kinases in human neurons , 1997, Annals of neurology.

[60]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[61]  Wei Zhang,et al.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. , 1997, The American journal of pathology.

[62]  G. Fontana,et al.  Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons , 1997, Journal of neuroscience research.

[63]  F. Chiu,et al.  HIV infection of human fetal neural cells is mediated by gp120 binding to a cell membrane-associated molecule that is not CD4 nor galactocerebroside , 1997, Brain Research.

[64]  C. Thiele,et al.  HIV-1 infection and the developing nervous system: lineage-specific regulation of viral gene expression and replication in distinct neuronal precursors. , 1997, Journal of neurovirology.

[65]  H. Gendelman,et al.  Development of laboratory and animal model systems for HIV‐1 encephalitis and its associated dementia , 1997, Journal of leukocyte biology.

[66]  J. Sodroski,et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.

[67]  F. Bloom,et al.  HIV in the brain: pathology and neurobehavioral consequences. , 1997, Journal of neurovirology.

[68]  L. Epstein,et al.  In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue. , 1996, Human pathology.

[69]  Francesco Scaravilli,et al.  Neuropathology of Early HIV‐1 Infection , 1996, Brain pathology.

[70]  S. Lipton,et al.  The Coat Protein gp120 of HIV‐1 Inhibits Astrocyte Uptake of Excitatory Amino Acids via Macrophage Arachidonic Acid , 1995, The European journal of neuroscience.

[71]  J. Church.  HIV-1 INFECTION OF SUBCORTICAL ASTROCYTES IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM , 1995, Pediatrics.

[72]  C. Thiele,et al.  HIV-1 infection of primary human neuroblasts. , 1995, Virology.

[73]  G. Pavlakis,et al.  Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function , 1995, Journal of virology.

[74]  R. Brownstone,et al.  Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.

[75]  S. Weis,et al.  Distribution of HIV genomic DNA in brains of AIDS patients. , 1995, Clinical and diagnostic virology.

[76]  C. Thiele,et al.  HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. , 1994, Virology.

[77]  M. Louder,et al.  Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues , 1994, Neurology.

[78]  L. Epstein,et al.  Detection of HIV-1 DNA in pediatric AIDS brain tissue by two-step ISPCR. , 1994, Advances in neuroimmunology.

[79]  J. Berman,et al.  The role of the blood-brain barrier in HIV infection of the central nervous system. , 1994, Advances in neuroimmunology.

[80]  W. Wachsman,et al.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection , 1992, Neurology.

[81]  P. Andrews,et al.  Differentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cells , 1992, Journal of virology.

[82]  Y. Stern.  The Impact of Human Immunodeficiency Virus on Cognitive Function a , 1991, Annals of the New York Academy of Sciences.

[83]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[84]  Q. Sattentau,et al.  HIV replicates in cultured human brain cells. , 1987, AIDS.

[85]  C. Cheng‐Mayer,et al.  Human immunodeficiency virus can productively infect cultured human glial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[86]  F. Chiodi,et al.  Infection of brain-derived cells with the human immunodeficiency virus , 1987, Journal of virology.

[87]  C. Wiley,et al.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[88]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[89]  J. Oleske,et al.  Progressive encephalopathy in children with acquired immue deficiency syndrome , 1985, Annals of neurology.